ARIAD Pharmaceuticals Inc (NASDAQ:ARIA)

7.22
Data as of Dec 19
 +0.61 / +9.23%
Today’s Change
4.80
Today|||52-Week Range
9.83
+5.87%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.4B

Company Description

ARIAD Pharmaceuticals, Inc. operates as a biopharmaceutical company, focuses on the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company has four products: Ridaforolimus, Ponatinib, AP1903 and AP26113. Its approach to structure-based drug design has led to three internally discovered, molecularly targeted product candidates for drug-resistant and difficult-to-treat cancers, including certain forms of chronic myeloid leukemia, soft tissue and bone sarcomas and non-small cell lung cancer. ARIAD Pharmaceuticals was founded by Harvey J. Berger in April 1991 and is headquartered in Cambridge, MA.

Contact Information

ARIAD Pharmaceuticals, Inc.
26 Landsdowne Street
Cambridge Massachusetts 02139-4234
P:(617) 494-0400
Investor Relations:

Employees

Shareholders

Other institutional37.59%
Individual stakeholders3.59%
Mutual fund holders28.31%

Top Executives

Harvey J. BergerChairman, President & Chief Executive Officer
Pierre F. DodionSenior VP-Corporate Development & Operations
Edward M. FitzgeraldChief Financial Officer, Treasurer & Executive VP
David C. DalgarnoVice President-Research Technologies
Timothy P. ClacksonChief Scientific Officer

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.